NVO Stock, Novo Nordisk A/S Information

Novo Nordisk is the parent company of a group engaged in the development, production and marketing of pharmaceuticals, biological solutions to industrial problems vitamins, dietary supplements and digestive aids. Co. operates on a worldwide basis in two business segments: Diabetes care: discovery, development, manufacturing and marketing of products within the areas of insulin and delivery systems and oral antidiabetic products OAD . Biopharmaceuticals: discovery, development, manufacturing and marketing of products within the therapy areas haemostasis management NovoSeven R RT , growth hormone therapy, hormone replacement therapy and other products.